Evidence map›Paper›PMID 30755292›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2019

Genetic and antigenic characterisation of influenza A(H3N2) viruses isolated in Yokohama during the 2016/17 and 2017/18 influenza seasons.

Chiharu Kawakami, Seiya Yamayoshi, Miki Akimoto, Kazuya Nakamura, Hideka Miura, Seiichiro Fujisaki, David J Pattinson, Kohei Shimizu, Hiroki Ozawa, Tomoko Momoki and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 3 countries.

Chiharu KawakamiYokohama City Institute of Public Health, Yokohama, Japan.
Seiya YamayoshiDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Miki AkimotoInfluenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Kazuya NakamuraInfluenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Hideka MiuraInfluenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Seiichiro FujisakiInfluenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
David J PattinsonCenter for Pathogen Evolution, University of Cambridge, Cambridge, UK.
Kohei ShimizuYokohama City Institute of Public Health, Yokohama, Japan.
Hiroki OzawaYokohama City Institute of Public Health, Yokohama, Japan.
Tomoko MomokiYokohama City Institute of Public Health, Yokohama, Japan.
Miwako SaikusaYokohama City Institute of Public Health, Yokohama, Japan.
Atsuhiro YasuharaDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Shuzo UsukuYokohama City Institute of Public Health, Yokohama, Japan.
Ichiro OkuboYokohama City Institute of Public Health, Yokohama, Japan.
Takahiro ToyozawaYokohama City Public Health Center, Yokohama, Japan.
Shigeo SugitaEquine Research Institute, Japan Racing Association, Tochigi, Japan.
Derek J SmithCenter for Pathogen Evolution, University of Cambridge, Cambridge, UK.
Shinji WatanabeInfluenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yoshihiro KawaokaDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
National Institute of Infectious Diseases · JPUniversity of Cambridge · GBJapan Racing Association · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfluenza A(H3N2) virus rapidly evolves to evade human immune responses, resulting in changes in the antigenicity of haemagglutinin (HA). Therefore, continuous genetic and antigenic analyses of A(H3N2) virus are necessary to detect antigenic mutants as quickly as possible.

aimWe attempted to phylogenetically and antigenically capture the epidemic trend of A(H3N2) virus infection in Yokohama, Japan during the 2016/17 and 2017/18 influenza seasons.

methodsWe determined the HA sequences of A(H3N2) viruses detected in Yokohama, Japan during the 2016/17 and 2017/18 influenza seasons to identify amino acid substitutions and the loss or gain of potential N-glycosylation sites in HA, both of which potentially affect the antigenicity of HA. We also examined the antigenicity of isolates using ferret antisera obtained from experimentally infected ferrets.

resultsInfluenza A(H3N2) viruses belonging to six clades (clades 3C.2A1, 3C.2A1a, 3C.2A1b, 3C.2A2, 3C.2A3 and 3C.2A4) were detected during the 2016/17 influenza season, whereas viruses belonging to two clades (clades 3C.2A1b and 3C.2A2) dominated during the 2017/18 influenza season. The isolates in clades 3C.2A1a and 3C.2A3 lost one N-linked glycosylation site in HA relative to other clades. Antigenic analysis revealed antigenic differences among clades, especially clade 3C.2A2 and 3C.2A4 viruses, which showed distinct antigenic differences from each other and from other clades in the antigenic map.

conclusionMultiple clades, some of which differed antigenically from others, co-circulated in Yokohama, Japan during the 2016/17 and 2017/18 influenza seasons.

Indexed as

EpidemicsGenetic VariationHemagglutinin Glycoproteins, Influenza VirusHemagglutininsHumansInfluenza A Virus, H3N2 SubtypeInfluenza, HumanJapanMolecular Sequence DataPhylogenyReverse Transcriptase Polymerase Chain ReactionRNA, ViralSeasonsSequence Analysis, DNAHemagglutinin Glycoproteins, Influenza VirusHemagglutininsRNA, ViralantigenicityepidemiologyglycosylationH3N2HAhaemagglutinininfluenzainfluenza virusJapansurveillanceviral infections

Identifiers

PMID30755292
PMCPMC6373070
OpenAlexW2911478656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.